Takeda Pharmaceutical
TAK
#489
Rank
NZ$82.38 B
Marketcap
NZ$24.76
Share price
0.14%
Change (1 day)
8.26%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): NZ$0.92

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ$0.97. a decrease over its 2024 EPS that were of NZ$0.52.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$0.39-25.03%
2024NZ$0.52-60.3%
2023NZ$1.3226.77%
2022NZ$1.04-44.4%
2021NZ$1.87722.5%
2020NZ$0.23-79.14%
2019NZ$1.09-43.73%
2018NZ$1.9470.24%
2017NZ$1.1445.47%
2016NZ$0.78-158.86%
2015NZ-$1.33-217.99%
2014NZ$1.13-34.43%
2013NZ$1.725.17%
2012NZ$1.63-49.61%
2011NZ$3.24-6.27%
2010NZ$3.4636.82%
2009NZ$2.53-28.28%
2008NZ$3.5224.96%
2007NZ$2.829.24%
2006NZ$2.583.21%
2005NZ$2.50-6.29%
2004NZ$2.6718.8%
2003NZ$2.2530.39%
2002NZ$1.7252.45%
2001NZ$1.131.77%
2000NZ$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.96 1,759.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.38 560.22%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$2.96 206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.66 1,211.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ-$6.90-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.40 45.11%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$22.42 2,221.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.19 540.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$13.06 1,252.93%๐Ÿ‡บ๐Ÿ‡ธ USA